Glaxo Settles Almost 25,000 Avandia Cases Under Mediation – Businessweek
Feb. 14 (Bloomberg) -- GlaxoSmithKline Plc settled almost 25,000 cases over its Avandia diabetes drug in mediation as multidistrict litigation begins to wind down, lawyers told a federal judge in Philadelphia. In November, U.S. District Judge ...
Subscribe to LegalLaw247.Com Newsletter